Mesoblast Ltd (MESO)
7.29
+0.09
(+1.25%)
USD |
NASDAQ |
May 02, 16:00
7.19
-0.10
(-1.37%)
After-Hours: 17:37
Mesoblast Revenue (TTM): 7.501M for June 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | 7.501M |
| March 31, 2023 | 7.586M |
| December 31, 2022 | 7.658M |
| September 30, 2022 | 8.06M |
| June 30, 2022 | 10.21M |
| March 31, 2022 | 9.983M |
| December 31, 2021 | 9.885M |
| September 30, 2021 | 9.739M |
| June 30, 2021 | 7.45M |
| March 31, 2021 | 6.146M |
| December 31, 2020 | 16.31M |
| September 30, 2020 | 16.05M |
| June 30, 2020 | 31.79M |
| March 31, 2020 | 33.56M |
| December 31, 2019 | 22.52M |
| September 30, 2019 | 22.26M |
| Date | Value |
|---|---|
| June 30, 2019 | 16.72M |
| March 31, 2019 | 15.60M |
| December 31, 2018 | 15.63M |
| September 30, 2018 | 27.31M |
| June 30, 2018 | 16.98M |
| March 31, 2018 | 16.11M |
| December 31, 2017 | 15.86M |
| September 30, 2017 | 2.90M |
| June 30, 2017 | 2.121M |
| March 31, 2017 | 27.45M |
| December 31, 2016 | 30.77M |
| September 30, 2016 | 34.35M |
| June 30, 2016 | 41.47M |
| March 31, 2016 | 19.84M |
| December 31, 2015 | 19.94M |
| September 30, 2015 | 20.31M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
6.146M
Minimum
Mar 2021
33.56M
Maximum
Mar 2020
14.32M
Average
9.983M
Median
Mar 2022
Revenue (TTM) Benchmarks
| Immuron Ltd | 2.349M |
| Alterity Therapeutics Ltd | -0.0416M |
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | 5.113M |
| Opthea Ltd | 0.1171M |